Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Col... ( CHADDS FORD Pa. Jan. 28 2011 /- Endo ...)

Endo Pharmaceuticals and Orion Corporation Begin Novel R&D Collaboration

Date:1/28/2011

CHADDS FORD, Pa., Jan. 28, 2011 /PRNewswire/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it has entered into a collaboration agreement with European-based Orion Corporation for the discovery, development and commercialization of assets in Oncology.

The formation of this R&D collaboration partnership allows the companies to bring forward a total of eight "discovery phase" candidates by combining an equal number of programs. The collaboration also allows both companies to exclusively license the others' development-ready programs at pre-determined stages and share all development costs.

"This alliance marks another milestone in the transformation of Endo's R&D platform," said Dr. Ivan Gergel M.D., executive vice president, Research & Development at Endo Pharmaceuticals. "We are excited about this opportunity to collaborate with an experienced partner like Orion and look forward to continuing to bring new therapies and healthcare solutions to payers, physicians and patients. This type of collaboration fits well into our new, efficient and effective virtual R&D model."

Dr. Reijo Salonen, senior vice president of Orion Corporation's Research and Development, commented: "I am very pleased with the collaboration agreement with Endo. This will immediately extend the Oncology R&D pipelines of both companies. The agreement is also perfectly in line with Orion's R&D strategy to focus on risk-sharing partnerships. We look forward to developing new cancer therapies for the patients jointly with Endo."

The companies will co-develop the assets coming out of this collaboration and share all development costs. Orion will have marketing rights in Europe, including Russia, while Endo will retain marketing rights for North America. The companies will pay cross royalties to each other on sales from their respect
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. Lotus Pharmaceuticals Provides Inner Mongolia Land Price Guidance from Cha You Qian Qi Government
3. JHP Pharmaceuticals and Putney Inc. Announce Multi-Year Contract Manufacturing Agreement
4. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
5. Amylin Pharmaceuticals Reports 2010 Financial Results
6. Prolong Pharmaceuticals Leases 24,000-Square-Foot Manufacturing Facility, Adds Facilities Veteran to Executive Team
7. Savient Pharmaceuticals Names John H. Johnson Chief Executive Officer
8. Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors
9. Optimer Pharmaceuticals Announces FDA Acceptance of NDA for Filing and Designation of Priority Review for Fidaxomicin for the Treatment of Clostridium difficile Infection (CDI)
10. CureFAKtor Pharmaceuticals Demonstrates that Novel Focal Adhesion Kinase (FAK) Inhibitors Targeted to Protein-Protein Binding Sites Inhibit Pancreatic Cancer Cells Growth
11. Amylin Pharmaceuticals to Webcast Year-End Financial Results

Post Your Comments:

(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ( http://www.oramed.com ... today that the United States Food and Drug Administration ... for ORMD-0801, its oral insulin capsule. "We ... proceed," stated Nadav Kidron , CEO ... for Oramed and we look forward to continuing to ...

(Date:5/16/2013)... ZURICH , May 17, 2013 ... Technology and Research (A*STAR) and Switzerland,s ... has been dosed in a Phase 1 clinical trial with ... Qbeta virus-like particle (VLP) technology. In this first Phase 1 ... candidate and its potential to protect against H1N1 influenza infection ...

(Date:5/16/2013)... , May 16, 2013 Nektar Therapeutics, (Nasdaq: ... W. Robin , is scheduled to present at the ... York at the Sheraton New York Hotel on ... The presentation will be accessible via a Webcast through ... of the Nektar website: http://www.nektar.com . This Webcast will ...

Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2 Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5 A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6 Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2

[0] Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.[0] A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing [0] Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City

... 2012 Enanta Pharmaceuticals, Inc. , a research ... molecule drugs in the infectious disease field, announced ... collaboration and license agreement with Novartis for the ... development candidate, EDP-239, from its NS5A hepatitis C ...

... 21, 2012 Fourth-Quarter 2011 Highlights: ... $1.08 increased 22.7 percent; Diluted EPS of $1.14, excluding ... with Express Scripts, Inc., increased 29.5 percent over $0.88 ... all intangible amortization and merger-related expenses, increased 26.3 percent ...

Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV Medco Delivers Record Fourth-Quarter and Full-Year 2011 Earnings

(Date:5/18/2013)... 2013 The “World Healthcare IT Market: ... the major market drivers, restraints, and opportunities in North ... Browse , 89 market data ... on "Healthcare IT Market" , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html ... reports. , The global healthcare IT market is expected ...

(Date:5/18/2013)... May 18, 2013 During Better Hearing ... should consider the legal protections they have, including the ... arise with their child’s treatment or hearing aid device, ... 1927, the American Speech-Language-Hearing Association has used the month ... to promote treatment, such as cochlear implants, which can ...

(Date:5/18/2013)... Adolescents, especially young males, who experiment with synthetic ... landing in emergency rooms across America. Recovery ... with a new treatment program for those addicted to ... the National Institute on Drug Abuse, synthetic marijuana has ... In 2012, 11 percent of high school seniors had ...

(Date:5/18/2013)... May 18, 2013 The American ... John A. Kitzhaber, M.D., (D) to sign a bill ... prohibiting minors under the age of 18 from tanning ... the third state in the nation to enact an ... similar indoor tanning bans for minors. Nationwide, 34 states ...

(Date:5/18/2013)... The topics that will be covered in the 1-day ... meetings, scrum artifacts, and scrum simulation (optional). One can earn ... These trainings are suitable for business analysts, project managers, developers, ... will be a part of the Scrum team, people outside ... and Scrum, but are unsure of what it is. ...

Breaking Medicine News(10 mins):Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2 Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3 Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 2 Health News:Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights 3 Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2 Health News:ASDSA Urges Oregon Governor to Sign Under-18 Indoor Tanning Restrictions 2 Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 2 Health News:Affordable Scrum Trainings In Irvine by Conscires Agile Practices 3

[0] Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets [0] Schachter, Hendy & Johnson PSC Lawyer Says Cochlear Implant Victims Should Know Their Legal Rights [0] Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates [0] ASDSA Urges Oregon Governor to Sign Under-18 Indoor Tanning Restrictions [0] Affordable Scrum Trainings In Irvine by Conscires Agile Practices

... Justin Timberlake; Sam, Younes and David Nazarian; and Sandy and ... at their annual Gala on Wednesday, November 4, 2009 at ... The event, sponsored by Lexus, benefitted the Cedar-Sinai Board of ... for the cause. , Justin Timberlake was ...

... YORK, Nov. 5 Wolters Kluwer Health has announced the ... the new position of Chief Nursing Officer (CNO) in a ... & Wilkins (LWW) journals and Ovid brands. LWW is a ... the global leader in electronic medical, scientific, and academic information ...

... Corporation (NYSE: KMB ) today announced the expiration ... Act with respect to its previously announced planned acquisition ... cash tender offer on October 20, 2009 to purchase ... tender offer will expire at midnight on November 17, ...

... Nov. 5 Narconon International,s management office in Los ... throughout the country in a combined effort to speak ... Red Ribbon Week. , The National Family Partnership,s (NFP) ... drug prevention activities and is held during the end ...

... Executive Vice President of the University of Pennsylvania for ... receive the Abraham Flexner Award for Distinguished Service to ... (AAMC). The award will be presented on Saturday, Nov. ... The Flexner Award was established by the ...

... ... increase awareness about the disease, raise funds for The Association’s global research program through an ... patients.” , ... (Vocus) November 5, 2009 -- As every caregiver who helps take care of someone living ...

Cached Medicine News:Health News:2009 Cedars-Sinai Board of Governors Gala Sponsored by Lexus Raises Over $2.6 Million 2 Health News:Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer; Strengthens Its Commitment to the Nursing Market 2 Health News:Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer; Strengthens Its Commitment to the Nursing Market 3 Health News:Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation 2 Health News:Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation 3 Health News:Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation 4 Health News:Narconon Centers Educate Thousands During Red Ribbon Week 2 Health News:Penn's Arthur H. Rubenstein receives Distinguished Service award from AAMC 2 Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 2 Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 3 Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 4 Health News:Caregiver's National Quilt Contest Supports ALS Association's Global Research Program 5

2009 Cedars-Sinai Board of Governors Gala Sponsored by Lexus Raises Over $2.6 Million Wolters Kluwer Health Appoints Anne Woods to Chief Nursing Officer; Strengthens Its Commitment to the Nursing Market Kimberly-Clark Corporation Announces Regulatory Clearance for Its Planned Acquisition of I-Flow Corporation Narconon Centers Educate Thousands During Red Ribbon Week Penn's Arthur H. Rubenstein receives Distinguished Service award from AAMC Caregiver's National Quilt Contest Supports ALS Association's Global Research Program

... color perception charts are recognized internationally ... determining color deficiency. With normal color ... all be visible. Each color test ... is specially printed to measure incrementally ...

Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...

... BD Edgeahead Stiletto / MVR knife. 1.1 ... insertion of 1.1 mm (19G) Cannula (5/bx, 1 ... knives are consistently sharp and precise. Sure grip ... edge. Tapered tip creates a fluid tight incision ...

Medicine Products:

Ishihara Color Test Ishihara Test Unlettered Pediatric 10 Plate Book Ishihara Test 14 Plate Book BD Edgeahead